VIR News
Vir Biotechnology, Inc.
$10.57
+$0.14(+1.34%)
--
Overall
--
Value
--
Tech
--
Quality
Market Cap
--
Volume
1.69M
52W Range
$4.82 - $12.00
Target Price
--
VIR news: the latest Vir Biotechnology, Inc. headlines, press releases and market updates, newest first.
Latest VIR News
- UBS Sticks to Its Hold Rating for Virtu Financial (VIRT)TipRanks Auto-Generated Intelligence Newsdesk · Oct 19, 2026
- Vidrala Sets October Date for Q3 2026 Results and Investor CallTipRanks Spain Auto-Generated Newsdesk · Oct 15, 2026
- Vir Biotechnology seals major oncology alliance with GileadTipRanks Auto-Generated Newsdesk · Oct 14, 2026
- Virtu Financial (VIRT) Gets a Sell from Morgan StanleyTipRanks Auto-Generated Intelligence Newsdesk · Oct 9, 2026
- Vir Biotechnology gains FDA Fast Track for VIR-5500TipRanks Auto-Generated Newsdesk · Oct 8, 2026
- Viridien updates shareholders on capital and voting rights structureTipRanks European Auto-Generated Newsdesk · Oct 6, 2026
- Vir Biotechnology Appoints Aziz Sawaf as New CFOTipRanks Auto-Generated Newsdesk · Oct 1, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VIR | $10.57 | +1.3% | 1.69M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |